A Prospective six sigma quality improvement trial to optimize universal screening for genetic syndrome among patients with young-onset colorectal cancer

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 13, Issue 7, 2015, Pages 865-872

  Dineen, Sean ^a   Lynch, Patrick M ^b   Rodriguez Bigas, Miguel A ^a   Bannon, Sarah ^a   Taggart, Melissa ^c   Reeves, Colleen ^a   Modaro, Cathy ^d   Overman, Michael ^e   Chang, George J ^a   Skibber, John M ^a   Nancy You, Y ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Division of Gastroenterology and Hepatology   (United States)

^c Departments of Cellular Pathology   (United States)

^d Quality Improvement   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; COLORECTAL CANCER; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC COUNSELING; GENETIC DISORDER; GENETIC SCREENING; GERMLINE MUTATION; HEALTH CARE QUALITY; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PATIENT CARE; PATIENT SAFETY; PROSPECTIVE STUDY; RISK ASSESSMENT; SECOND DEGREE RELATIVE; TOTAL QUALITY MANAGEMENT; ADOLESCENT; CLINICAL TRIAL; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EARLY CANCER DIAGNOSIS; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; ONSET AGE; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EARLY DETECTION OF CANCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY IMPROVEMENT; YOUNG ADULT;

EID: 84938152790     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2015.0103     Document Type: Article

References (39)

1. st Century. Washington, DC: National Academies Press; 2001.
2. O'Connell JB, Maggard MA, Liu JH, et al. Rates of colon and rectal cancers are increasing in young adults. Am Surg 2003;69:866-872.
3. Ahnen DJ, Wade SW, Jones WF, et al. The increasing incidence of young-onset colorectal cancer: a call to action. Mayo Clin Proc 2014;89:216-224.
4. Siegel RL, Jemal A, Ward EM. Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 2009;18:1695-1698.
5. You YN, Xing Y, Feig BW, et al. Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med 2012;172:287-289.
6. Hampel H. NCCN increases the emphasis on genetic/familial high-risk assessment in colorectal cancer. J Natl Compr Canc Netw 2014;12:829-831.
7. Lynch PM. When and how to perform genetic testing for inherited colorectal cancer syndromes. J Natl Compr Canc Netw 2013;11:1577-1583.
8. Ladabaum U, Wang G, Terdiman J, et al. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med 2011;155:69-79.
9. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-932.
10. Moreira L, Balaguer F, Lindor N, et al. Identification of Lynch syndrome among patients with colorectal cancer. JAMA 2012;308:1555-1565.
11. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 2009;11:35-41.
12. Beamer LC, Grant ML, Espenschied CR, et al. Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results. J Clin Oncol 2012;30:1058-1063.
13. Mvundura M, Grosse SD, Hampel H, et al. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med 2009;12:93-104.
14. Sturgeon D, McCutcheon T, Geiger TM, et al. Increasing Lynch syndrome identification through establishment of a hereditary colorectal cancer registry. Dis Colon Rectum 2013;56:308-314.
15. Provenzale D, Jasperson K, Ahnen DJ, et al. NCCN Clinical Practice Guidelines in Oncology: Colorectal Cancer Screening. Version 1, 2015. Available at: NCCN.org. Accessed June 15, 2015.
16. Lindor NM, Petersen GM, Hadley DW, et al. Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006;296:1507-1517.
17. Weissman SM, Burt R, Church J, et al. Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline. J Genet Couns 2012;21:484-493.
18. Burt RW, Cannon JA, David DS, et al. Colorectal cancer screening. J Natl Compr Canc Netw 2013;11:1538-1575.
19. Burt RW, Barthel JS, Dunn KB, et al. NCCN Clinical Practice Guidelines in Oncology. Colorectal cancer screening. J Natl Compr Canc Netw 2010;8:8-61.
20. Benson AB III, Venook AP, Bekaii-Saab T, et al. Colon cancer, version 3.2014. J Natl Compr Canc Netw 2014;12:1028-1059.
21. Anning L, Koo N, Neely J, et al. Management of young onset colorectal cancer: divergent practice in the East of England. Colorectal Dis 2011;13:e297-302.
22. Singh H, Schiesser R, Anand G, et al. Underdiagnosis of Lynch syndrome involves more than family history criteria. Clin Gastroenterol Hepatol 2010;8:523-529.
23. Overbeek LI, Hoogerbrugge N, van Krieken JH, et al. Most patients with colorectal tumors at young age do not visit a cancer genetics clinic. Dis Colon Rectum 2008;51:1249-1254.
24. Nicolay CR, Purkayastha S, Greenhalgh A, et al. Systematic review of the application of quality improvement methodologies from the manufacturing industry to surgical healthcare. Br J Surg 2012;99:324-335.
25. Sedlack JD. The utilization of six sigma and statistical process control techniques in surgical quality improvement. J Healthc Qual 2010;32:18-26.
26. Chassin MR. Is health care ready for Six Sigma quality? Milbank Q 1998;76:565-591, 510.
27. Aboelmagd MG. Six Sigma quality: a structured review and implications for future research. Int J Qual Reliab Manage 2010;27:268-317.
28. Khan MH, Howard TJ, Fogel EL, et al. Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center. Gastrointest Endosc 2007;65:247-252.
29. Frankel HL, Crede WB, Topal JE, et al. Use of corporate Six Sigma performanceimprovement strategies to reduce incidence of catheter-related bloodstream infections in a surgical ICU. J Am Coll Surg 2005;201:349-358.
30. Vasen HFA, Abdirahman M, Brohet R, et al. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 2010;138:2300-2306.
31. Parry S, Win AK, Parry B, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 2010;60:950-957.
32. Schmeler KM, Lynch HT, Chen LM, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006;354:261-269.
33. Heald B, Plesec T, Liu X, et al. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center. J Clin Oncol 2013;31:1336-1340.
34. Bannon SA, Mork M, Vilar E, et al. Patient-reported disease knowledge and educational needs in Lynch syndrome: findings of an interactive multidisciplinary patient conference. Hered Cancer Clin Pract 2014;12:1.
35. Vest JR, Gamm LD. A critical review of the research literature on Six Sigma, Lean and StuderGroup's Hardwiring Excellence in the United States: the need to demonstrate and communicate the effectiveness of transformation strategies in healthcare. Implement Sci 2009;4:35.
36. Coit DG, Andtbacka R, Anker CJ, et al. Melanoma, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2013;11:395-407.
37. Theriault RL, Carlson RW, Allred C, et al. Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2013;11:753-760; quiz 761.
38. Greene RA, Beckman H, Chamberlain J, et al. Increasing adherence to a community-based guideline for acute sinusitis through education, physician profiling, and financial incentives. Am J Manag Care 2004;10:670-678.
39. Grol R. Improving the quality of medical care: building bridges among professional pride, payer profit, and patient satisfaction. JAMA 2001;286:2578-2585.